|
Market Closed -
Nasdaq
06:00:00 19/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 9.990 USD | -1.48% |
|
-4.77% | -17.71% |
| 15/09 | Ocular Therapeutix, Inc. Completes Pre-NDA Meeting With FDA For AXPAXLI In Wet AMD | CI |
| 15/09 | Ocular Therapeutix Plans to File Eye Disease Drug Marketing Application in Q4 | MT |
| Market Cap | 2.19B 1.91B 1.81B 1.64B 3.07B 211B 3.09B 21.64B 8.35B 107B 8.24B 8.06B 344B | P/E 2026 * |
-6.7x | P/E 2027 * | -7.17x |
|---|---|---|---|---|---|
| Enterprise Value | 1.82B 1.58B 1.5B 1.36B 2.54B 174B 2.55B 17.91B 6.91B 88.59B 6.82B 6.67B 285B | EV / Sales 2026 * |
34.3x | EV / Sales 2027 * | 20.8x |
| Free-Float |
99.07% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OCUL | Delayed | |
CBOE
| OCUL | Real-time | |
|
Tradegate
| 0OT | Real-time | |
|
Boerse Muenchen
| 0OT | Real-time | |
|
Deutsche Boerse AG
| 0OT | Delayed | |
|
Börse Stuttgart
| 0OT | Delayed | |
|
Berne S.E.
| 0OT | End-of-day quote |
Last Transcript: Ocular Therapeutix, Inc.
| 1 day | -1.48% | ||
| 1 week | -4.77% | ||
| Current month | -4.77% | ||
| 1 month | -9.26% | ||
| 3 months | +5.94% | ||
| 6 months | +17.67% | ||
| Current year | -17.71% |
| 1 week | 9.81 |  | 10.89 |
| 1 month | 9.81 | | 11.62 |
| Current year | 6.23 | | 13.03 |
| 1 year | 6.23 | | 16.44 |
| 3 years | 2 | | 16.44 |
| 5 years | 2 | | 16.44 |
| 10 years | 2 | | 24.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pravin Dugel
CEO | Chief Executive Officer | 62 | 15/04/2024 |
Jason Robins
DFI | Director of Finance/CFO | 50 | 20/01/2026 |
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 49 | 20/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Warden
CHM | Chairman | 57 | 01/07/2019 |
| Director/Board Member | 78 | 05/11/2012 | |
Leslie Williams
BRD | Director/Board Member | 66 | 20/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/8/26 | Sell | Chief Operating Officer | -1,099 | 0.0005% | ||
| 25/8/26 | Don | Chief Executive Officer | -100,184 | 0.0473% | ||
| 24/8/26 | Sell | Executive/Senior Manager | -3,035 | 0.0014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.48% | -4.77% | -21.40% | +200.90% | 2.19B | |
| +0.04% | +3.34% | +51.12% | +101.82% | 1,028B | |
| -0.09% | +1.66% | +55.02% | +66.18% | 651B | |
| -0.02% | +2.66% | +18.91% | +71.47% | 466B | |
| -1.22% | +3.66% | +36.44% | +38.32% | 346B | |
| -0.79% | +2.73% | +19.03% | +25.08% | 266B | |
| +0.58% | +6.76% | +11.13% | +16.52% | 259B | |
| +1.55% | +2.20% | +39.81% | +46.55% | 208B | |
| +0.79% | +1.84% | -28.27% | -56.71% | 191B | |
| -0.52% | +4.45% | +32.12% | +98.51% | 186B | |
| Average | +0.03% | +2.45% | +21.39% | +60.86% | 360.39B | |
| Weighted average by Cap. | +0.23% | +3.09% | +35.11% | +61.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 52.93M 46.15M 43.58M 39.57M 74.14M 5.08B 74.45M 522M 201M 2.58B 199M 194M 8.31B | 102M 89.36M 84.38M 76.62M 144M 9.83B 144M 1.01B 390M 5B 385M 376M 16.09B |
| Net income | -334M -292M -275M -250M -468M -32.08B -470M -3.3B -1.27B -16.31B -1.26B -1.23B -52.48B | -324M -283M -267M -243M -454M -31.13B -456M -3.2B -1.23B -15.83B -1.22B -1.19B -50.92B |
| Net Debt | -378M -330M -311M -283M -530M -36.27B -532M -3.73B -1.44B -18.44B -1.42B -1.39B -59.34B | -66M -57.55M -54.34M -49.35M -92.46M -6.33B -92.84M -651M -251M -3.22B -248M -242M -10.36B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | USD 9.990 | -1.48% | 4,100,930 |
| 17/09/26 | USD 10.14 | +2.74% | 2,311,414 |
| 16/09/26 | USD 9.870 | -3.14% | 3,405,745 |
| 15/09/26 | USD 10.19 | -4.94% | 2,098,599 |
| 14/09/26 | USD 10.72 | +2.19% | 1,623,509 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OCUL Stock
Select your edition
All financial news and data tailored to specific country editions
